Eli Lilly Surges with a 45% Revenue Jump to $12.7 Billion in Q1, Fueled by Mounjaro and Zepbound
Eli Lilly's Q1 revenue soared by 45% to $12.73 billion, thanks to strong sales of Mounjaro and Zepbound. The company also reported a 23% increase in net income to $2.76 billion and...
